Nature Communications

Gut bacterial chemical linked to lower thinking scores in adults

An observational study of 1,196 adults without cognitive impairment linked higher blood imidazole propionate to lower thinking-test scores and Alzheimer’s-related biological markers.

Paper by Vaibhav Vemuganti, Jea Woo Kang, Qijun Zhang, +20 more authorsFederico E. Rey · University of Wisconsin–Madison

Our read

Mechanisms
Studied:
Cohort study of 1,196 cognitively unimpaired adults
What changed:
Higher plasma ImP levels were associated with lower preclinical cognitive scores
The catch:
ImP was measured by untargeted metabolomics with arbitrary values, not absolute concentrations
Stake:
An author founded Implexion Pharma and two hold shares in it. An author founded Roxbiosens and holds shares in it.
In the record:
One of 4 papers on imidazole propionate on record: 2 with results in people.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Among 1,196 adults without cognitive impairment, whose average age was 61.2 years, researchers measured blood imidazole propionate, a chemical made by gut bacteria, in an observational study. Higher levels were associated with lower cognitive scores and biological markers of Alzheimer’s disease and related dementias. Participants in the highest quarter of blood levels had lower initial cognitive scores and steeper age-related declines than those in the lowest quarter.

A Mendelian randomization analysis, which used inherited DNA differences, also linked genetically predicted higher levels to greater Alzheimer’s risk. In separate experiments, sustained imidazole propionate dosing worsened Alzheimer’s-like changes in male mice. Tests in human brain blood-vessel cells grown in the lab found that the chemical weakened the cells’ barrier function.

Why it matters

For Alzheimer’s disease and related dementias, the authors suggest that targeting this gut bacterial chemical may offer a strategy to modify risk.

Caveats

The human analyses did not test whether lowering the chemical would change cognition or Alzheimer’s risk. All 1,196 adults lacked cognitive impairment, and people with a parental history of Alzheimer’s dementia were overrepresented in one contributing cohort.

From the paper

Result

Consistent with this notion, data from the most recent and largest GWAS meta-analysis for AD revealed that the T allele of rs7969761 was directionally consistently associated with increased risk of AD dementia (OR = 1.02; 95% CI 1.01-1.04; P = 2.8 × 10⁻³).

Results, Genetically increased plasma ImP levels are associated with increased AD risk

Limitation

Our human cohort consisted primarily of cognitively unimpaired individuals, which may limit the generalizability of our findings to broader or more diverse populations, including those with varying degrees of cognitive impairment or differing geographic and demographic backgrounds.

Discussion

Quoted word for word from the full text on PubMed Central.

Comments

Be the first to comment.